Director, Licensing Transaction

Puesto: DIRECTOR, LICENSING TRANSACTION
* Lead the strategic framing and structuring of licensing transactions for pre-clinical and clinical-stage assets identified through scouting activities.
* Develop deal hypotheses and transaction frameworks that balance scientific potential, commercial value, risk mitigation, and financial constraints.
* Translate complex scientific and commercial assessments into clear deal structures and negotiation positions.
* Establish and maintain alignment with external partners on deal structure, timelines, and key negotiation principles throughout the transaction process.
* Represent Almirall in partnering conferences, industry events, and external meetings to build relationships and advance transaction opportunities.

Business Relationship Management & Alignment Contract Negotiation & Execution
* Lead end-to-end negotiation of licensing contracts, including option agreements, license agreements, research collaborations, and related transaction documents.
* Work closely with Legal, and senior BD leadership to negotiate contractual terms regulating the business relationship including governance structures, development plans, IP provisions, Reps & Warranties, Termination and other critical contractual elements.
* Ensure negotiated terms appropriately reflect insights from Due Diligence and address identified risks and opportunities.
* Drive negotiations towards successful closure while maintaining positive partner relationships and protecting Almirall's strategic and financial interests.
* Coordinate execution logistics including internal approvals, governance body presentations, signing procedures, and announcement planning. Post-Deal Transition & Integration Support
* Ensure seamless handover of executed agreements to internal project teams and alliance management function.
* Maintain partner relationships during transition period to ensure smooth operational handover.
* Capture learnings from each transaction to continuously improve BD&L processes and approaches.
** REQUIRED EDUCATION AND EXPERIENCE
*** Advanced degree in life sciences, business, or related field (PhD, Pharm

D, MSc, MD, MBA, or JD). Combination of scientific and business education is strongly preferred.
* Significant experience in pharmaceutical/biotech business development, licensing, or related transaction-focused roles is essential.
* Minimum 8 years relevant pharma/biotech experience, ideally with exposure to immunology or dermatology.
* Including at least 5 years of direct experience leading licensing negotiations and closing complex pharma transactions (platform technologies, research collaborations, early or late-stage clinical assets).
* Consulting, investment banking, or VC background in healthcare transactions also considered a plus.
* Demonstrated track record of successfully negotiating and closing multiple licensing deals or strategic partnerships (detailed deal sheet will be required).
* Experience managing complex cross-functional alignment processes and driving internal consensus.
** PREFERRED SKILLS AND COMPETENCIES
*** Strategic deal-making mindset with ability to structure transactions that create value for both parties while managing risk.
* Strong understanding of pharmaceutical development, regulatory pathways, and commercialization to shape deal structure.
* Knowledge of immune inflammation or autoimmune diseases, ideally in dermatology, is a plus.
* Exceptional negotiation skills with demonstrated ability to build trust, find creative solutions, and close complex agreements.
* Outstanding interpersonal and relationship management abilities; skilled at building credibility with diverse stakeholders from scientists to executives.
* Ability to resolve conflicts in a constructive way and to leverage opposing ideas to generate new insights and build alignment.
* Expert at navigating ambiguity, managing complexity, and driving clarity in high-stakes, multi-party negotiations.
* Winning and proactive mindset, driving opportunities in a fast-paced environment.
* Ability to articulate deal rationale, risks, and value proposition clearly to diverse audiences, including executive committees and external partners.
* Strong financial acumen and…